Increasing Exposure To Fungus Spores Driving Infection Rates Due To Environmental And Human Activity Changes: Key Factor Driving The Growth In The Valley Fever Market

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected Valley Fever Market Size During the Forecast Period?
The valley fever market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing climate change effects driving fungal spread, increasing research funding for Valley Fever treatments, rising investments in TH*Care, rising demand for specialized diagnostic laboratories, and rising incidence of Valley Fever in non-endemic regions.

In the upcoming years, a robust growth is projected in the valley fever market, inflating its size to $1.29 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 5.4%. Various factors contribute to this rise during the forecasting period such as the growing embrace of telemedicine, accelerated research concerning antifungal resistance, increased funding towards vaccine creation, heightened populace mobility through areas with high risk, and greater access to antifungal remedies. The forecast period also expects to witness significant trends such as advances in technology, demand for antifungal medication, vaccine progression, telemedicine adoption, and international cooperation.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22166

What Are the High-Growth Segments in the Valley Fever Market?
The valley fever market covered in this report is segmented -

1) By Types Of Treatment: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment
2) By Site Of Infection: Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection
3) By End-Users: Human, Cattle, Sheep And Goats, Camel, Other End-Users

Subsegmentss:

1) By Fluconazole Type: Oral Fluconazole, Intravenous Fluconazole
2) By Itraconazole Type: Capsule Itraconazole, Oral Solution Itraconazole
3) By Voriconazole Type: Oral Voriconazole, Intravenous Voriconazole
4) By Posaconazole Type: Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole
5) By Other Treatment Types: Combination Therapy, Adjunctive Therapy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22166&type=smp

What Key Drivers Are Expected to Influence Future Valley Fever Market Growth?
The anticipated increase in exposure to fungus spores is predicted to fuel the growth of the valley fever market. Fungus spores, which are minuscule reproductive cells generated by fungi, can be disseminated through air, water, or physical surfaces, thus enabling the fungi to propagate and reproduce in novel environments. Deforestation and fluctuating weather conditions have led to increased exposure to these spores as they disturb the soil, triggering spore release, which increases the risk of infections like valley fever, particularly in dry areas where the coccidioides fungus flourishes. Treatment for valley fever aids those exposed to these spores by alleviating symptoms, preventing complications, and inhibiting fungal growth, thereby enhancing patient recovery and quality of life. For example, as stated by the International Society for Infective Diseases, a US-based non-profit organization, in September 2024, about 6.5 million individuals are impacted each year by invasive fungal infections, resulting in almost 3.8 million deaths, out of which about 2.5 million are directly due to these infections. Consequently, the increasing exposure to fungus spores is spurring the growth of the valley fever market. The market's growth is also being driven by the expansion of TH*Care facilities due to advancements in medical technology. The growth of TH*Care facilities, which include crucial physical facilities, systems and tools required to provide effective TH*Care services, is expected to boost the valley fever market. The expansion of these facilities is largely due to advancements in medical technology. Innovations in fields such as telemedicine, robotic surgery, and AI-driven diagnostics necessitate upgraded facilities, specialized equipment, and optimized TH*Care delivery systems to enhance patient outcomes and operational efficiency. TH*Care facilities aid in managing valley fever through early diagnosis, antifungal treatments, patient education, and continual care to manage symptoms and mitigate complications. For example, according to the American Hospital Association, a US-based non-profit organization, there was an increase in the total number of hospitals in the United States from 6,093 in 2022 to 6,120 in 2024. Therefore, this increase in TH*Care infrastructure is propelling the growth of the valley fever market.

Which Companies Hold the Largest Share Across Different Valley Fever Market Segments?
Major companies operating in the valley fever market are Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden TH*Care, Kabir Lifesciences

What Trends Are Driving Growth in The Valley Fever Market?
Leading businesses in the valley fever marketplace are prioritizing the development of pioneering vaccines to combat the escalating issue of fungal infections. The aim of these valley fever vaccines is to safeguard individuals through the utilization of sophisticated science and production methods, thereby improving community health and protection. An example of this happened in August 2024 when Anivive Lifesciences Inc., a veterinary pharmaceutical establishment located in the US, was granted a contract amounting to an upper limit of $33 million from the National Institute of Allergy and Infectious Diseases (NIAID), a governmental agency, also based in the US, to engineer a vaccine for human Valley Fever. This investment will facilitate further manufacturing, the creation of a formula, comprehensive safety assessments, and a phase 1 clinical trial, with the goal of producing the inaugural preventative solution for serious systemic fungal infection.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/valley-fever-global-market-report

What Are the Emerging Geographies for The Valley Fever Market Growth?
North America was the largest region in the valley fever market in 2024. The regions covered in the valley fever market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Valley Fever Market?
2. What is the CAGR expected in the Valley Fever Market?
3. What Are the Key Innovations Transforming the Valley Fever Industry?
4. Which Region Is Leading the Valley Fever Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.